METLIFE INC

For the period ended Dec 31, 2023. Filed Feb 16, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 16, 2024

MET$101.67+3.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(In millions, except per share data)

	2023	2022	2021
Revenues
Premiums	$44,283	$48,510	$41,152
Universal life and investment-type product policy fees	5,152	5,225	5,244
Net investment income	19,908	15,916	21,395
Other revenues	2,526	2,630	2,619
Net investment gains (losses)	(2,824)	(1,260)	1,543
Net derivative gains (losses)	(2,140)	(2,251)	(3,257)
Total revenues	66,905	68,770	68,696
Expenses
Policyholder benefits and claims	44,590	49,507	43,118
Policyholder liability remeasurement (gains) losses	(45)	114	(172)
Market risk benefit remeasurement (gains) losses	(994)	(3,674)	(1,237)
Interest credited to policyholder account balances	7,860	3,894	5,571
Policyholder dividends	622	706	880
Other expenses	12,710	11,859	12,018
Total expenses	64,743	62,406	60,178
Income (loss) before provision for income tax	2,162	6,364	8,518
Provision for income tax expense (benefit)	560	1,062	1,642
Net income (loss)	1,602	5,302	6,876
Less: Net income (loss) attributable to noncontrolling interests	24	18	21
Net income (loss) attributable to MetLife, Inc.	1,578	5,284	6,855
Less: Preferred stock dividends	198	185	195
Preferred stock redemption premium	—	—	6
Net income (loss) available to MetLife, Inc.’s common shareholders	$1,380	$5,099	$6,654

Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$1.82	$6.35	$7.71
Diluted	$1.81	$6.30	$7.65

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.